[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503013":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":64,"collaborators":19,"id":66,"slug":19,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":19,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":19,"enrollmentInfo":74,"targetDuration":19,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Aptissen SA","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SYNOLIS VA 80\u002F160","EXPERIMENTAL","Single guided intra-articular injection of SYNOLIS VA 80\u002F160",[13],"Device: SYNOLIS VA 80\u002F160",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","SYNOLIS VA 80\u002F160 (hyaluronic acid 80 mg, sorbitol 160 mg)",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Eduard Vidovic, MD","CONTACT","+41225522104","clinic@aptissen.com",[27,42,53],{"facility":28,"status":29,"city":30,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Service de Rhumatologie, Hôpital Nord Franche-Comté","RECRUITING","Belfort","France","FR",{"type":34,"coordinates":35},"Point",[36,37],6.85385,47.64218,{"lat":37,"lon":36},[40],{"name":41,"role":23,"phone":19,"phoneExt":19,"email":19},"Thierry Conrozier, Dr",{"facility":43,"status":29,"city":44,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD","Dunkirk",{"type":34,"coordinates":46},[47,48],2.37681,51.0344,{"lat":48,"lon":47},[51],{"name":52,"role":23,"phone":19,"phoneExt":19,"email":19},"Nicolas Jan, Dr",{"facility":54,"status":29,"city":55,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille","Lille",{"type":34,"coordinates":57},[58,59],3.05512,50.63391,{"lat":59,"lon":58},[62],{"name":63,"role":23,"phone":19,"phoneExt":19,"email":19},"Henri Migaud, Pr",{"type":65,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100503013",false,"NCT05829733","6-month Efficacy and Safety of Synolis VA 80\u002F160 in Hip Osteoarthritis","6-month Evaluation of the Efficacy and Safety of Synolis VA 80\u002F160 in the Treatment of Symptomatic Hip Osteoarthritis","Inclusion Criteria:\n\n* Patient over 18 years of age,\n* Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria:\n* Treated hip pain: Oxford score ≥ 21\u002F60,\n* Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),\n* Symptoms related to osteoarthritis of the hip for at least 2 months,\n* Failure of treatments (i.e., inadequate or ineffective response to analgesics and\u002For NSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21\u002F60),\n* Informed consent form signed by the patient,\n* The patient has never had a visco supplement injection or corticosteroid injection in the hip to be treated (or more than 6 months old).\n\nExclusion Criteria:\n\n* Pregnancy,\n* Participation in another clinical trial,\n* Skin lesion near the injection site,\n* Recent or old infection of the affected joint,\n* Patient with a programmed arthroplasty,\n* Patient with a pathology that makes decision-making impossible,\n* The patient must not have undergone non-prosthetic hip-conserving surgery such as osteotomy or arthroscopy less than 12 months old.","ALL","18 Years",{"count":75,"type":76},70,"ESTIMATED","INTERVENTIONAL",[79],"NA","Multicenter, independent study of Synolis VA 80\u002F160 over a period of 6 months",[82],"Osteoarthritis, Hip",[84,85,86],"Osteoarthritis","Hip osteoarthritis","Hyaluronic acid","2025-12-05",{"date":89,"type":90},"2025-12-12","ACTUAL",{"date":92,"type":90},"2024-05-27",{"date":94,"type":76},"2027-04",{"name":5,"class":6},3]